Business Wire

Alucent Biomedical Announces First Patient Enrolled in the First-in-Human Clinical Trial of Its Novel AlucentNVS Technology for Arteriovenous Fistula (AVF) in People with End ...

SALT LAKE CITY--(BUSINESS WIRE)--Alucent Biomedical Inc., a company dedicated to developing and commercializing its breakthrough AlucentNVS technology for the treatment of vascular disease, announced ...
NJBIZ

Region’s first minimally invasive endovascular procedure for Hemodialysis performed at Jefferson Health

A Jefferson Health interventional radiologist became the first physician in the Philadelphia/South Jersey region to perform a new procedure that creates an arteriovenous (AV) fistula, necessary for ...
News Medical

Ellipsys System can help create durable vascular access for end-stage renal disease

A new study shows significant benefits of the Ellipsys ® Vascular Access System in easily and safely creating durable vascular access for end-stage renal disease (ESRD) patients who require ...
TCTMD

Concept Medical Inc. Granted 'Breakthrough Device Designation' From the FDA for Its MagicTouch AVF Sirolimus Coated Balloon

The FDA received Concept Medical Inc. (CMI) request to designate MagicTouch AVF as a Breakthrough Device in July 2019. The proposed indications for the Breakthrough Device Designation for “The ...
NJBIZ

Overlook Medical Center introduces non-surgical dialysis procedure

Overlook Medical Center, part of Atlantic Health System, has unveiled the WavelinQ, a device that offers a new, non-surgical way to prepare patients for dialysis. According to Overlook officials, it ...
BioWorld

Flow Forward raises $7M in series A funding for hemodialysis AFE pump

The Arteriovenous Fistula Eligibility system, courtesy of Flow Forward. Med-tech startup Flow Forward LLC said it has raised a total of $7 million in its series A round. The news comes around the same ...